RxSight, Inc. (NASDAQ: RXST) reported Q3 EPS of $0.00, $0.25 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $35.3 million versus the consensus estimate of $35.06 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.